JP2004510749A5 - - Google Patents

Download PDF

Info

Publication number
JP2004510749A5
JP2004510749A5 JP2002532257A JP2002532257A JP2004510749A5 JP 2004510749 A5 JP2004510749 A5 JP 2004510749A5 JP 2002532257 A JP2002532257 A JP 2002532257A JP 2002532257 A JP2002532257 A JP 2002532257A JP 2004510749 A5 JP2004510749 A5 JP 2004510749A5
Authority
JP
Japan
Prior art keywords
agonist
ppardelta
activator
ppar delta
synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002532257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004510749A (ja
Filing date
Publication date
Priority claimed from GBGB0024362.6A external-priority patent/GB0024362D0/en
Application filed filed Critical
Publication of JP2004510749A publication Critical patent/JP2004510749A/ja
Publication of JP2004510749A5 publication Critical patent/JP2004510749A5/ja
Pending legal-status Critical Current

Links

JP2002532257A 2000-10-05 2001-10-02 No阻害またはtnf阻害に関連した疾病の治療におけるpparデルタ活性化因子の使用 Pending JP2004510749A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024362.6A GB0024362D0 (en) 2000-10-05 2000-10-05 Medicaments
PCT/GB2001/004370 WO2002028433A2 (en) 2000-10-05 2001-10-02 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition

Publications (2)

Publication Number Publication Date
JP2004510749A JP2004510749A (ja) 2004-04-08
JP2004510749A5 true JP2004510749A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=9900710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002532257A Pending JP2004510749A (ja) 2000-10-05 2001-10-02 No阻害またはtnf阻害に関連した疾病の治療におけるpparデルタ活性化因子の使用

Country Status (6)

Country Link
US (1) US20040029938A1 (cg-RX-API-DMAC7.html)
EP (1) EP1324773A2 (cg-RX-API-DMAC7.html)
JP (1) JP2004510749A (cg-RX-API-DMAC7.html)
AU (1) AU2001292044A1 (cg-RX-API-DMAC7.html)
GB (1) GB0024362D0 (cg-RX-API-DMAC7.html)
WO (1) WO2002028433A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160845A0 (en) 2001-09-14 2004-08-31 Tularik Inc Linked biaryl compounds
EP1637161A4 (en) * 2003-04-22 2007-06-27 Astellas Pharma Inc MEANS FOR THE TREATMENT OF NEURODEGENERATIVE ILLNESSES OF THE BRAIN WITH PPAR [delta] AGONIST
AR044399A1 (es) * 2003-05-20 2005-09-14 Novartis Ag Compuestos heterociclicos y su uso como activadores de receptores de ppar. composiciones farmaceuticas que los contienen
AU2004247355A1 (en) 2003-06-06 2004-12-23 F. Hoffmann-La Roche Ag Aniline derivatives
BRPI0412236A (pt) 2003-07-02 2006-09-12 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(delta) e/ou ppar(alfa), e utilização desses compostos
AU2005231358A1 (en) * 2004-04-01 2005-10-20 Aventis Pharmaceuticals Inc. Use of PPR delta agonists for treating demyelinating diseases
US7126825B2 (en) * 2004-12-07 2006-10-24 Cleavage Enterprise Co., Ltd. Combined chip/heat-dissipating metal plate and method for manufacturing the same
US20110092517A1 (en) * 2009-08-14 2011-04-21 Cerenis Therapeutics S.A. & Nippon Chemiphar Co., Ltd. Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1856997A (en) * 1996-02-02 1997-08-22 Merck & Co., Inc. Method for raising hdl cholesterol levels
AU8355998A (en) * 1997-07-24 1999-02-16 Yamanouchi Pharmaceutical Co., Ltd. Medicinal compositions with cholesterol-lowering effect
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
EP1170008A1 (en) * 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Valproic acid and derivatives thereof as histone deacetylase inhibitors

Similar Documents

Publication Publication Date Title
JP2004510750A5 (cg-RX-API-DMAC7.html)
JP2004505105A5 (cg-RX-API-DMAC7.html)
JP2002543065A5 (cg-RX-API-DMAC7.html)
JP2006526590A5 (cg-RX-API-DMAC7.html)
JP2002161074A5 (cg-RX-API-DMAC7.html)
JP2008543854A5 (cg-RX-API-DMAC7.html)
JP2004517813A5 (cg-RX-API-DMAC7.html)
JP2005526011A5 (cg-RX-API-DMAC7.html)
JP2008519847A5 (cg-RX-API-DMAC7.html)
JP2009541387A5 (cg-RX-API-DMAC7.html)
JP2005527576A5 (cg-RX-API-DMAC7.html)
JP2004504347A5 (cg-RX-API-DMAC7.html)
JP2008524127A5 (cg-RX-API-DMAC7.html)
JP2007502817A5 (cg-RX-API-DMAC7.html)
CN1210027C (zh) 治疗溃疡的药物组合物及其应用
JP2005517677A5 (cg-RX-API-DMAC7.html)
JP2023022236A5 (cg-RX-API-DMAC7.html)
JP2005511516A5 (cg-RX-API-DMAC7.html)
JP2007515467A5 (cg-RX-API-DMAC7.html)
JP2005513014A5 (cg-RX-API-DMAC7.html)
JP2008520662A5 (cg-RX-API-DMAC7.html)
JP2005532397A5 (cg-RX-API-DMAC7.html)
JP2004538314A5 (cg-RX-API-DMAC7.html)
JP2011508779A5 (cg-RX-API-DMAC7.html)
JP2007506664A5 (cg-RX-API-DMAC7.html)